Using naltrexone to validate a human laboratory test system to screen new medications for alcoholism (TESMA)- a randomized clinical trial

This registered clinical trial sought to validate a laboratory test system devised to screen medications for alcoholism treatment (TESMA) under different contingencies of alcohol reinforcement. Forty-six nondependent, but at least medium-risk drinkers were given the opportunity to earn intravenous i...

Descripción completa

Detalles Bibliográficos
Autores principales: Spreer, Maik, Grählert, Xina, Klut, Ina-Maria, Al Hamdan, Feras, Sommer, Wolfgang H., Plawecki, Martin H., O’Connor, Sean, Böttcher, Michael, Sauer, Cathrin, Smolka, Michael N., Zimmermann, Ulrich S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076427/
https://www.ncbi.nlm.nih.gov/pubmed/37019884
http://dx.doi.org/10.1038/s41398-023-02404-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076427/
https://www.ncbi.nlm.nih.gov/pubmed/37019884
http://dx.doi.org/10.1038/s41398-023-02404-7

Ejemplares similares